Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health Reform Magnifies Payers' Invisible Place At The Licensing Table

This article was originally published in The Pink Sheet Daily

Executive Summary

Report from Licensing Executives Society meeting: Survey shows many already have taken action oncomparative effectiveness.

You may also be interested in...

Strange Bedfellows: Regulators May Revive Biotech Deals And IPOs

Still mourning the loss of IPOs and desperate for exits, biotechs could be forgiven for being pessimistic. But some experts say health reform and other new regulations will renew the value of innovative drugs and revive the crucial public markets

Stop The Bleeding: Sanofi-Aventis Looks To Sell A Generic Plavix In Europe

If a bioequivalent version of the clot buster launches in France, Sanofi is preparing to roll out its own generic version of clopidogrel.

Highlights from PSA: Will Investors Rise Over Reimbursement Hurdles?

At our September 2009 Pharmaceutical Strategic Alliances meeting, a recurring theme concerned the growing importance of factoring reimbursement hurdles into drug development decisions. Where does that start? In some cases, at Series A.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts